[Prevention of thromboembolic risk in spinal cord injury: results of a questionnaire concerning short- and long-term treatment].
The use of medications to prevent thromboembolic risk is recommended in spinal cord injury patients during the early phase, but there is no consensus on treatment duration and modalities. Differences in practice include choice of medication (heparin, low molecular weight heparin, inhibitors of platelet aggregation), treatment duration (three to six months or more), and criteria for discontinuation of treatment. To determine usual practice modalities for prophylaxis of deep vein thrombosis in spinal cord injury patients, and to identify determinant criteria. Postal survey of physiatrists taking care of spinal cord injury patients. The questionnaire asks the physician about his usual practice modalities (choice of treatments, paraclinical tests, use of compressive stockings, during and after the first six months and criteria for discontinuation of treatments). Forty-two questionnaires were suitable for analysis. Results show that usual practice modalities combine venous doppler testing only in the setting of suggestive clinical signs, treatment with low molecular weight heparin during three to six months, and combination with compressive stockings. Despite the absence of consensus on this question, our results are consistent with data from the literature, which identify acute spinal cord lesions as a factor of high risk for deep vein thrombosis. The risk decreases during the chronic phase. Adjuvant techniques include mobilisation, elastic compression, and standing. A study of long-term treatment modalities after deep vein thrombosis would be needed.